Found: 7
Select item for more details and to access through your institution.
Survival impact of primary tumor resection in de novo metastatic breast cancer patients (GEICAM/El Alamo Registry).
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-019-55765-9
- By:
- Publication type:
- Article
Derived Neutrophil-to-Lymphocyte Ratio Predicts Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2021.827625
- By:
- Publication type:
- Article
Palbociclib and ribociclib in breast cancer: consensus workshop on the management of concomitant medication.
- Published in:
- Therapeutic Advances in Medical Oncology, 2019, v. 11, p. 1, doi. 10.1177/1758835919833867
- By:
- Publication type:
- Article
Palbociclib and ribociclib in breast cancer: consensus workshop on the management of concomitant medication.
- Published in:
- Therapeutic Advances in Medical Oncology, 2019, v. 11, p. N.PAG, doi. 10.1177/1758835919833867
- By:
- Publication type:
- Article
A Phase 1/2A trial of idroxioleic acid: first-in-class sphingolipid regulator and glioma cell autophagy inducer with antitumor activity in refractory glioma.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 5, p. 811, doi. 10.1038/s41416-023-02356-1
- By:
- Publication type:
- Article
Clinical and economic impact of the 21-gene recurrence score assay in adjuvant therapy decision making in patients with early-stage breast cancer: pooled analysis in 4 Basque Country university hospitals.
- Published in:
- ClinicoEconomics & Outcomes Research, 2018, v. 10, p. 189, doi. 10.2147/CEOR.S146095
- By:
- Publication type:
- Article
A prospective study on tumour response assessment methods after neoadjuvant endocrine therapy in early oestrogen receptor-positive breast cancer.
- Published in:
- Breast Cancer Research, 2024, v. 26, n. 1, p. 1, doi. 10.1186/s13058-023-01756-8
- By:
- Publication type:
- Article